Genital Herpes simplex virus Type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease

Journal of Infectious Diseases

Volumn 209, Issue 4, 2014, Pages 510-522

  Nixon, Briana ^a   Fakioglu, Esra ^a   Stefanidou, Martha ^a   Wang, Yanhua ^b   Dutta, Monica ^a   Goldstein, Harris ^a   Herold, Betsy C ^a  

^a Department of Pediatrics ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

coinfection; female genital tract; herpes simplex virus 2; human immunodeficiency virus 1; mouse model; sexually transmitted infections

Indexed keywords

COINFECTION; FEMALE GENITAL TRACT; HERPES SIMPLEX VIRUS-2; HUMAN IMMUNODEFICIENCY VIRUS-1; MOUSE MODEL; SEXUALLY TRANSMITTED INFECTIONS;

ANIMALS; COINFECTION; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HISTOCYTOCHEMISTRY; HIV INFECTIONS; HIV-1; INFLAMMATION; LYMPH NODES; MICE; MICE, TRANSGENIC; NERVOUS SYSTEM DISEASES; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; VAGINA; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 84893305227     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit472     Document Type: Article

References (36)

1. Nagot N, Ouedraogo A, Defer MC, Vallo R, Mayaud P, Van de Perre P. Association between bacterial vaginosis and herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm Infect 2007; 83:365-8.
2. Wald A, Corey L. How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis? J Infect Dis 2003; 187:1509-12.
3. Corey L. Synergistic copathogens-HIV-1 and HSV-2. N Engl J Med 2007; 356:854-6.
4. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-19.
5. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-9.
6. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-71.
7. Chen L, Jha P, Stirling B, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies. PLoS One 2007; 2:e1001.
8. Ameli N, Bacchetti P, Morrow RA, et al. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations. AIDS 2006; 20:1051-8.
9. Patterson J, Hitti J, Selke S, et al. Genital HSV detection among HIV-1-infected pregnant women in labor. Infect Dis Obstet Gynecol 2011; 2011:157680.
10. Crostarosa F, Aravantinou M, Akpogheneta OJ, et al. A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy. PLoS One 2009; 4:e8060.
11. Joseph A, Sango K, Goldstein H. Novel mouse models for understanding HIV-1 pathogenesis. Methods Mol Biol 2009; 485:311-27.
12. Zariffard MR, Saifuddin M, Finnegan A, Spear GT. HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5. AIDS Res Hum Retroviruses 2009; 25: 1157-64.
13. Zhang JX, Diehl GE, Littman DR. Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PLoS One 2008; 3:e2035.
14. Sun J, Soos T, Kewalramani VN, et al. CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate. J Virol 2006; 80:1850-62.
15. Segarra TJ, Fakioglu E, Cheshenko N, et al. Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety. PLoS One 2011; 6:e27675.
16. Hendrickson BA, Guo J, Brown I, et al. Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection. Virology 2000; 271:155-62.
17. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokineinduced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238:800-2.
18. Wilson SS, Cheshenko N, Fakioglu E, Mesquita PM, Keller MJ, Herold BC. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety. Antivir Ther 2009; 14:1113-24.
19. John M, Keller MJ, Fam EH, et al. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis 2005; 192:1731-40.
20. Wahl SM, McNeely TB, Janoff EN, et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis 1997; 3 (Suppl 1):S64-9.
21. Hannila SS, Siddiq MM, Carmel JB, et al. Secretory leukocyte protease inhibitor reverses inhibition by CNS myelin, promotes regeneration in the optic nerve, and suppresses expression of the transforming growth factor-β signaling protein Smad2. J Neurosci 2013; 33:5138-51.
22. Suh HS, Choi N, Tarassishin L, Lee SC. Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12). PLoS One 2012; 7:e35115.
23. Wang X, Li X, Xu L, et al. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Mol Pharmacol 2003; 64:833-40.
24. Fakioglu E,Wilson SS, Mesquita PM, et al. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism. J Virol 2008; 82:9337-44.
25. Nakayama K, Nakamura H, Koga M, et al. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses 2012; 28:702-14.
26. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183:2593-603.
27. Suryawanshi A, Veiga-Parga T, Rajasagi NK, et al. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol 2011; 187:1919-30.
28. McKinnon LR, Nyanga B, Chege D, et al. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 2011; 187:6032-42.
29. Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112:2826-35.
30. Mugo N, Dadabhai SS, Bunnell R, et al. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya. Sex Transm Dis 2011; 38:1059-66.
31. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182:1090-6.
32. Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 2008; 65:596-600.
33. Britton CB, Mesa-Tejada R, Fenoglio CM, Hays AP, Garvey GG, Miller JR. A new complication of AIDS: thoracic myelitis caused by herpes simplex virus. Neurology 1985; 35:1071-4.
34. Corral I, Quereda C, Navas E, Perez-Elias MJ, Jover F, Moreno S. Sacral myeloradiculitis complicating genital herpes in a HIV-infected patient. Int J STD AIDS 2005; 16:175-7.
35. Li A, Felix JC, YangW, Jain JK. Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users. Fertil Steril 2008; 90:872-5.
36. Farley N, Bernstein DI, Bravo FJ, Earwood J, Sawtell N, Cardin RD. Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy. Antiviral Res 2010; 86:188-95.